{
  "docId": "019dd923-5e88-73ef-bd5a-c462f4eb9bc8",
  "docSlug": "93f4426c37f34bad",
  "documentTitle": "QDEL JPM 2024 Presentation vfinal 010824  9 am PT",
  "authorId": "JPMorgan",
  "authorName": "QuidelOrtho",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 20,
  "pageCount": 33,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a timeline-based comparison to justify market positioning.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "callout_box",
    "process_diagram",
    "other"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-c462f4eb9bc8/20",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-c462f4eb9bc8",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-c462f4eb9bc8.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-c462f4eb9bc8#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.28,
        "x": 0.69,
        "y": 0.13
      },
      "kind": "callout",
      "text": "Why we're bullish on Savanna: Strong customer overlap, Cost-effective multi-analyte panels, HSV/VZV novel panel, Market expansion, ~$3B addressable market.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a4470fc-1cb1-4b7d-b4bf-296b3f3f37af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Why we're bullish on Savanna",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-28a9-71be-8078-409eda0bfac1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.37,
        "y": 0.38
      },
      "kind": "list",
      "text": "2006 / 2007 clinical launch; $150M addressable market; 450 placements",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d13b7fc7-d9c7-4698-b52f-88a1621d4437",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "list",
      "text": "C. 2000: PCR performed in centralized labs for complex diagnostics. C. 2010: PCR expands into clinical settings. C. 2020: Pandemic drives greater awareness and demand within POC settings.",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "824be3bc-b263-4522-98d8-5c815c0ad574",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "addressable market: $3B",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-28a9-71be-8078-44e092833876",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Public company materials, analyst estimates, Mordor Intelligence",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2089e8d0-7fb0-446a-960d-ee403b7bb5d1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Savanna is the Right Product at the Right Time",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77531d27-3a4c-49de-870b-e61df4de7d33",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.03,
        "y": 0.17
      },
      "kind": "title",
      "text": "Evolution of near-patient PCR testing",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be2e1550-4da8-46f3-8c20-5d2710cddd68",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "872497cd-d36b-424c-ab55-5409f6949cfa",
      "evidence": "Chronological progression of PCR testing",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 27,
      "from": 5,
      "beatId": "06ab681f-ad25-4783-bba8-0dbe1fc47283",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Not explicitly mentioned but implied through business units and leadership",
      "beatSlug": "sequoia-pitch-team",
      "evidence": "The document implies a strong team through its business units and growth strategy.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 21,
      "from": 19,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "413c44ff-ee22-44d0-a55f-af8ea936c7d2",
      "evidence": "The document presents Savanna as a revenue growth opportunity.",
      "position": 0,
      "objective": "What if QuidelOrtho doesn't leverage Savanna for revenue growth?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}